Sunday, June 20, 2021

Glenmark Life Sciences IPO Date, Review, Price, Form & Market Lot Details

Glenmark Life Sciences IPO to hit the market on 27 July 2021 as per the RHP filed on 19 July 2021. The company to raise ₹1514 crores via initial public offer with a face value of ₹2 per equity share. The IPO comprises fresh issue of 1060 crores and offer for sale of 6,300,000 equity shares of Glennmark Pharmceuticals Limited .
 
Glenmark Life Sciences IPO to hit the market on 27 July 2021 and closes on 29 July 2021. The company plans to raise ₹1514 crore through the initial public offerings. Glenmark Life Sciences is an API arm of Glenn Mark Pharma, a leading drug maker. They are one of the leading developer and manufacturer of Active Pharmaceutical Ingredients (APIs). They are making high-quality drugs by unlocking the possibilities of science. They created the strong relationship with leading pharmaceutical companies that have helped us expand our product offerings and geographic reach. They have 120 API in their catalogue. They supply their API to 540 pharma companies in India and overseas. They export their products in Europe, Latin America, North America, Japan, and the rest of the world. Check out Glenmark Life Sciences IPO details.

Important Details:
According to the DRHP, the proceeds from the IPO will be used for:
  • Payment of outstanding purchase consideration to the promoter for the spin-off of the API businessb)
  •  Funding capital expenditure requirements
  • General corporate purposes

How to apply in Share Holder Quota:
If you want to apply Glenmark Life Sciences IPO in the share holder quota, you should buy at least 1 share of Glenmark Pharma. It should be in your demat account when the company announce their IPO date or before RHP.
Note: According to RHP there is no Share Holders Quota.
 
Equity Shares outstanding prior to the Issue = 10,78,04,950 Shares
Fresh Issue of 1,47,22,222 Shares Rs.720 = Rs.1,060.00 Crores
Offer for Sale of 63,00,000 Shares Rs.720 = Rs.453.60 Crores
Equity Shares outstanding after the Issue = 12,25,27,172 Shares

Category-wise Break up:
Anchor: 63,06,667 Shares = 454.08 Crores
QIB: 42,04,444 Shares = 302.72 Crores
NII: 31,53,333 Shares = 227.04 Crores
RII: 73,57,778 Shares = 529.76 Crores (Lot size: 20 = 3,67,889 Forms)
Total Issue: 2,10,22,222 Shares = 1513.60 Crores

Subscription Required for 1X
RII: 3,67,889 Forms
NII: 227.04 Crores

Financial Information (Basis of Valuation)

The information is collated from the following documents:
1) RHP = Red Herring Prospectus Dated July 19, 2021 (358 pages)

EPS for FY18-19 >>> Rs.24.64 (Page #82 of RHP)
EPS for FY19-20 >>> Rs.29.04 (Page #82 of RHP)
EPS for FY20-21 >>> Rs.32.61 (Page #82 of RHP)

RoNW for FY18-19 >>> 99.25% (Page #83 of RHP)
RoNW for FY19-20 >>> 77.94% (Page #83 of RHP)
RoNW for FY20-21 >>> 46.71% (Page #83 of RHP)

NAV as on March 31, 2021 was Rs.69.82 (Page #83 of RHP)

Listed Industry Peer Group:
  • Divis Laboratories
  • Laurus Labs
  • Shilpa Medicare
  • Aarti Drugs
  • Solara Active Pharma Sciences
Glenmark Life Sciences Logo


    Glenmark Life Sciences IPO Review

    • Adding Soon

    Brokerage Firm IPO Reviews

    • ICICI Securities: Adding Soon
    • Motilal Oswal: Adding Soon
    • Capital Market: Adding Soon
    • Ventura Securities Limited: Adding Soon
    • KR Choksey: Adding Soon
    • GEPL Capital Ltd: Adding Soon

    Glenmark Life Sciences IPO Date & Price Band

     IPO Open:  27 July 2021
     IPO Close:  29 July 2021
     IPO Size:  Approx ₹1514 Crores
     Fresh Issue:  Approx ₹1060 Crores
     Offer for Sale:  Approx ₹454 Crores, 63,00,000 Shares
     Face Value:  ₹2 Per Equity Share
     Price Band:  ₹695 to ₹720 Per Share
     Listing on:  BSE & NSE
     Retail Portion:  35%
     Equity:  - Shares

    Glenmark Life Sciences IPO Market Lot

    The Glenmark Life Sciences IPO minimum market lot is 20 shares with ₹14,400 application amount. The retail investors can apply up-to 13 lots with 260 shares or ₹187,200 amount.
     
     Minimum Lot Size:  Minimum 20 Shares
     Minimum Amount:  ₹14,400
     Maximum Lot Size:  Maximum 260 Shares
     Maximum Amount:  ₹187,200

    Glenmark Life Sciences IPO Date, Time Table, Allotment & Listing

    The Glenmark Life Sciences IPO date is 27 July 2021 and the IPO close date is 29 July 2021. The allotment date is 03 August 2021 and the IPO may list on 06 August 2021.
     
     Basis of Allotment:  27 July 2021
     Basis of Allotment:  29 July 2021
     Basis of Allotment:  03 August 2021
     Refunds:  04 August 2021
     Credit to Demat Account:  05 August 2021
     Listing Date:  06 August 2021

    Glenmark Life Sciences IPO Form

    How to apply the Glenmark Life Sciences IPO? You can apply Glenmark Life Sciences IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Glenmark Life Sciences IPO in the Invest section. The other option you can apply Glenmark Life Sciences IPO via IPO forms download via NSE and BSE. Check out the Glenmark Life Sciences forms - click NSE Forms & BSE Forms blank IPO forms download, fill and submit in your bank or with your broker.


    Glenmark Life Sciences Company Financial Report

      ₹ in Crores

    Revenue Expenses PAT
    2018 ₹0.25 ₹0.26 -₹0.43
    2019 ₹886.87 ₹658.59 ₹195.59
    2020 ₹1549.30 ₹1128.24 ₹313.10
    2021 9M
    ₹1418.47 ₹1088.15 ₹246.90

    Company Promoters

    • Glenmark Pharmaceuticals Limited

    About Glenmark Life Sciences

    We are a leading developer and manufacturer of Active Pharmaceutical Ingredients (APIs)

    We are in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, we have established strong relationships with leading global generic pharmaceutical companies that have helped us expand our product offerings and geographic reach. We work with 16 of the 20 largest generic companies globally. (Source: A Year of Surprises Shakes Up Off-Patent Industry” | Informa, 2020)

    With 120 APIs in our catalogue, we are blending innovation and operational excellence to deliver on the promise of service, reliability, and consistent product quality.

    Powered by our massive, world-class manufacturing and research capabilities, we supply high-quality APIs to more than 540 pharma companies in multiple countries.

    Quick Links

    DRHP Draft Prospectus
    RHP Draft Prospectus

    Glenmark Life Sciences IPO Registrar

    KFin Technologies Private Limited (Formerly known as
    Karvy Fintech Private Limited)
    Selenium Tower-B
    Plot No-31 and 32, Financial District
    Nanakramguda, Serilingampally
    Hyderabad, Rangareddi 500032
    Telangana, India
    Tel: +91 40 6716 2222
    E-mail: glenmark.ipo@kfintech.com
    Investor Grievance E-mail: einward.ris@kfintech.com
    Website: www.kfintech.com
    Contact Person: M Murali Krishna
    SEBI Registration No.: INR000000221
    Note: Check Glenmark Life Sciences IPO allotment status on KFintech website allotment URL. Click Here

    Glenmark Life Sciences IPO Lead Managers

    • Kotak Mahindra Capital Company Limited
    • BofA Securities India Limited
    • Goldman Sachs (India) Securities Private Limited
    • DAM Capital Advisors Limited
    • BOB Capital Markets Limited
    • SBI Capital Markets Limited

    Company Address

    Glenmark Life Sciences Limited
    Registered Office:
    Plot No. 170-172, Chandramouli Industrial Estate,
    Mohol Bazarpeth, Solapur 413 213, Maharashtra
    Corporate Office:
    Glenmark House, B. D. Sawant Marg,
    Andheri (East), Mumbai 400099,
    Maharashtra, India
    Tel: +912189 234456/ +912189 234246
    Website: www.glenmarklifesciences.com
    Contact Person: Rudalf Corriea
    (Company Secretary and Compliance Officer)
    E-mail: complianceofficer@glenmarklifesciences.com
    Corporate Identity Number: U74900PN2011PLC139963

    Glenmark Life Sciences IPO FAQs


    What is Glenmark Life Sciences IPO?

    Glenmark Life Sciences IPO is a main-board IPO. They are going to raise ₹1514 Crores via IPO. The issue is priced at ₹695 to ₹720 per equity share. The IPO to be listed on BSE & NSE.

    When Glenmark Life Sciences IPO will open?

    The IPO is to open on 27 July 2021 for QIB, NII, and Retail Investors.

    What is Glenmark Life Sciences IPO Investors Portion?

    The investors' portion for QIB 50%, NII 15%, and Retail 35%.

    How to Apply the Glenmark Life Sciences IPO?

    You can apply Glenmark Life Sciences IPO via ASBA online via your bank account. You can also apply ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.

    How to Apply the India Pesticides IPO through Zerodha?

    Log in to Console in Zerodha Website or in Application. Go to Portfolio and Click on IPO. You will see the IPO Name "Glenmark Life Sciences". Click on Bid Button. Enter your UPI ID, Quantity and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Zerodha.

    How to Apply the India Pesticides IPO through Upstox?

    Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name "Glenmark Life Sciences". Click on Bid Button. Confirm your application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox.

    What is Glenmark Life Sciences IPO Size?

    Glenmark Life Sciences IPO size is ₹1515 crores.

    What is Glenmark Life Sciences IPO Price Band?

    Glenmark Life Sciences IPO Price Band is ₹695 to ₹720.

    What is Glenmark Life Sciences IPO Minimum and Maximum Lot Size?

    The minimum bid is 20 Shares with ₹14,400 amount while maximum bid is 260 shares with ₹187,200.

    What is Glenmark Life Sciences IPO Allotment Date?

    Glenmark Life Sciences IPO allotment date is 03 August 2021.

    What is Glenmark Life Sciences IPO Listing Date?

    Glenmark Life Sciences IPO listing date is 06 August 2021. The IPO to list on BSE and NSE.

    Note: The Glenmark Life Sciences IPO details added as it is officially announced. The IPO grey market premium (Glenmark Life Sciences IPO Premium) started. You can check our IPO grey market page for daily updates.)